Elevation Oncology Inc. Rings the Closing Bell
ABOUT THIS EVENT
Elevation Oncology (Nasdaq: ELEV), a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Shawn Leland, PharmD, RPh, Founder and Chief Executive Officer of Elevation Oncology, rings the Closing Bell.